International consensus statement on the use of uterotonic agents during caesarean section
The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Abstract
Summary: It is routine to give a uterotonic drug following delivery of the neonate during caesarean section. However, there is much heterogeneity in the relevant research, which has largely been performed in low‐risk elective cases or women with uncomplicated labour. This is reflected in considerable variation in clinical practice. There are significant differences between dose requirements during elective and intrapartum caesarean section. Standard recommended doses are higher than required, with the potential for acute cardiovascular adverse effects. We recommend a small initial bolus dose of oxytocin, followed by a titrated infusion. The recommended doses of oxytocin may have to be increased in women with risk factors for uterine atony. Carbetocin at equipotent doses to oxytocin has similar actions, while avoiding the requirement for a continuous infusion after the initial dose and reducing the need for additional uterotonics. As with oxytocin, carbetocin dose requirements are higher for intrapartum caesarean sections. A second‐line agent should be considered early if oxytocin/carbetocin fails to produce good uterine tone. Women with cardiac disease may be very sensitive to the adverse effects of oxytocin and other uterotonics, and their management needs to be individualised.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The oxytocin receptor system: structure, function, and regulation
Gimpl, G., & Fahrenholz, F. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.629 · Cited by 3,089 · cited 2×
“Similarly to other G protein-coupled receptors, oxytocin receptors undergo rapid homologous desensitisation [22].”
BackgroundPractice Bulletin No. 183: postpartum hemorrhage
(2017) · Obstetrics & Gynecology · doi:10.1097/aog.0000000000002351 · Cited by 1,406
Prevention and Management of Postpartum Haemorrhage: Green‐top Guideline No. 52
(2017) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.14178 · Cited by 756
Acta Anaesthesiologica Scandinavica
(2010) · Acta Anaesthesiologica Scandinavica · doi:10.1111/(issn)1399-6576 · Cited by 736
The British Journal of Obstetrics and Gynaecology—1992
Paintin, D. B. (1992) · BJOG: An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.1992.tb14379.x · Cited by 545
Clinical pharmacology and therapeutics
Fenn, G. C. (1990) · Postgraduate Medical Journal · doi:10.1136/pgmj.66.778.686 · Cited by 479
The Journal of Obstetrics and Gynecology of India
(2013) · The Journal of Obstetrics and Gynecology of India · doi:10.1007/13224.0975-6434 · Cited by 415
Active Management of the Third Stage of Labour: Prevention and Treatment of Postpartum Hemorrhage
Leduc, D., Senikas, V., Lalonde, A. B., Leduc, D., Ballerman, C., Biringer, A., Delaney, M., Duperron, L., Girard, I., Jones, D., et al. (2009) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)34329-8 · Cited by 369
Sentilhes, L., Vayssière, C., Deneux-Tharaux, C., Aya, A. G., Bayoumeu, F., Bonnet, M.-P., Djoudi, R., Dolley, P., Dreyfus, M., Ducroux-Schouwey, C., et al. (2016) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2015.12.012 · Cited by 327
Thomas, J. S., Koh, S. H., & Cooper, G. M. (2007) · British Journal of Anaesthesia · doi:10.1093/bja/ael302 · Cited by 311 · cited 1×
“min 1 increase seen after the same 5 IU dose given as a bolus [39].”
BackgroundThe Bristol third stage trial: active versus physiological management of third stage of labour.
Prendiville, W. J., Harding, J. E., Elbourne, D. R., & Stirrat, G. M. (1988) · BMJ · doi:10.1136/bmj.297.6659.1295 · Cited by 306
Prostaglandins for preventing postpartum haemorrhage
Tunçalp, Ö., Hofmeyr, G. J., & Gülmezoglu, A. M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000494.pub4 · Cited by 296
Dyer, R. A., Reed, A. R., van Dyk, D., Arcache, M. J., Hodges, O., Lombard, C. J., Greenwood, J., & James, M. F. (2009) · Anesthesiology · doi:10.1097/aln.0b013e3181b437e0 · Cited by 296
Self-citationInternational journal of gynaecology and obstetrics
ScienceDirect (1969) · Cited by 260
Oxytocin Requirements at Elective Cesarean Delivery: A Dose-Finding Study
Carvalho, J. C. A., Balki, M., Kingdom, J., & Windrim, R. (2004) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000142709.04450.bd · Cited by 249
Self-citationEvidence‐based strategies for preventing drug administration errors during anaesthesia
Jensen, L. S., Merry, A. F., Webster, C. S., Weller, J., & Larsson, L. (2004) · Anaesthesia · doi:10.1111/j.1365-2044.2004.03670.x · Cited by 231 · cited 1×
“Strategies that have been described to minimise the risk of drug errors include: carefully reading the ampoule label; coloured labels for the syringe; separate trays in the workspace; pre-filled syringes; and only drawing up oxytocin when it is required [97, 98].”
BackgroundUterotonic agents for preventing postpartum haemorrhage: a network meta-analysis
Gallos, I. D., Williams, H. M., Price, M. J., Merriel, A., Gee, H., Lissauer, D., Moorthy, V., Tobias, A., Deeks, J. J., Widmer, M., et al. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd011689.pub2 · Cited by 228
Prevention and treatment of postpartum hemorrhage in low-resource settings
Lalonde, A., & FIGO Safe Motherhood and Newborn Health (SMNH) Committee (2012) · International Journal of Gynecology & Obstetrics · doi:10.1016/j.ijgo.2012.03.001 · Cited by 223 · cited 1×
“FIGO (International Federation ofGynecology andObstetrics) SafeMotherhood and NewbornHealthCommittee Prevention and treatment of postpartumhemorrhage in low-resource settings [11] Within 1 min of delivery of the infant, palpate the abdomen to rule out the presence of an additional infant(s) and give oxytocin 10 IU int…”
MethodDansereau, J., Joshi, A. K., Helewa, M. E., Doran, T. A., Lange, I. R., Luther, E. R., Farine, D., Schulz, M., Horbay, G. L. A., Griffin, P. C., et al. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70271-1 · Cited by 222
Svanström, M. C., Biber, B., Hanes, M., Johansson, G., Näslund, U., & Bålfors, E. M. (2008) · British Journal of Anaesthesia · doi:10.1093/bja/aen071 · Cited by 216 · cited 1×
“A bolus dose of 10 IU oxytocin produced transient ST depression in approximately 50% of women undergoing caesarean section with spinal anaesthesia, but this effect was also seen in a similar percentage of nonpregnant and non-anaesthetised women given the same dose [52].”
BackgroundOxytocin revisited: Its role in cardiovascular regulation
Gutkowska, J., & Jankowski, M. (2012) · Journal of Neuroendocrinology · doi:10.1111/j.1365-2826.2011.02235.x · Cited by 208 · cited 1×
“Oxytocin has its primary effect on oxytocin receptors in the uterus; it also has adverse effects that aremediated by oxytocin receptors as well as other receptors in the cardiovascular system [1].”
BackgroundShields, L. E., Smalarz, K., Reffigee, L., Mugg, S., Burdumy, T. J., & Propst, M. (2011) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2011.06.084 · Cited by 205 · cited 1×
“There is some evidence that an escalating strategy for the management of increased bleeding after vaginal delivery can reduce postpartum haemorrhage rates [92], and thismay also be applicable at caesarean section [93].”
BackgroundMinimum Oxytocin Dose Requirement After Cesarean Delivery for Labor Arrest
Balki, M., Ronayne, M., Davies, S., Fallah, S., Kingdom, J., Windrim, R., & Carvalho, J. C. A. (2006) · Obstetrics & Gynecology · doi:10.1097/01.aog.0000191529.52596.c0 · Cited by 168
Self-citationCarbetocin for preventing postpartum haemorrhage
Su, L., Chong, Y. S., & Samuel, M. (2012) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005457.pub4 · Cited by 155 · cited 1×
“A Cochrane review published in 2012 included 11 studies on 2635 women comparing a 100-lg bolus dose of carbetocin, by various routes of administration, with other uterotonic agents, following either vaginal delivery or caesarean section [72].”
MethodMinimum effective bolus dose of oxytocin during elective Caesarean delivery
Butwick, A. J., Coleman, L., Cohen, S. E., Riley, E. T., & Carvalho, B. (2010) · British Journal of Anaesthesia · doi:10.1093/bja/aeq004 · Cited by 152 · cited 2×
“[24] performed a dose–response study of oxytocin doses between 0 IU and 5 IU.”
BackgroundMethodSelf-citationHemodynamic Changes Associated with Spinal Anesthesia for Cesarean Delivery in Severe Preeclampsia
Dyer, R. A., Piercy, J. L., Reed, A., Lombard, C. J., Schoeman, L., & James, M. F. (2008) · Anesthesiology · doi:10.1097/01.anes.0000311153.84687.c7 · Cited by 152
Self-citationEffect of carbetocin, a long-acting oxytocin analog on the postpartum uterus
Hunter, D. J. S., Schulz, P., & Wassenaar, W. G. (1992) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1992.103 · Cited by 134
Meher, S., Cuthbert, A., Kirkham, J. J., Williamson, P. R., Abalos, E. J., Aflaifel, N. B., Bhutta, Z. A., Bishop, A., Blum, J., Collins, P. W., et al. (2018) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/1471-0528.15335 · Cited by 131
Moertl, M., Friedrich, S., Kraschl, J., Wadsack, C., Lang, U. E., & Schlembach, D. (2011) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2011.03022.x · Cited by 126 · cited 1×
“Studies comparing the cardiovascular effects of standard 100 lg doses of carbetocin and 5 IU oxytocin during caesarean section under spinal anaesthesia have shown essentially indistinguishable hemodynamic effects for the twodrugs [59, 75].”
BackgroundChanges in Blood Pressure and Cardiac Output during Cesarean Delivery
Rosseland, L. A., Hauge, T. H., Grindheim, G., Stubhaug, A., & Langesæter, E. (2013) · Anesthesiology · doi:10.1097/aln.0b013e31829416dd · Cited by 120 · cited 2×
“Studies comparing the cardiovascular effects of standard 100 lg doses of carbetocin and 5 IU oxytocin during caesarean section under spinal anaesthesia have shown essentially indistinguishable hemodynamic effects for the twodrugs [59, 75].”
BackgroundSheehan, S. R., Montgomery, A. A., Carey, M., McAuliffe, F. M., Eogan, M., Gleeson, R., Geary, M., Murphy, D. J., & The ECSSIT Study Group (2011) · BMJ · doi:10.1136/bmj.d4661 · Cited by 119
Negative Inotropic and Chronotropic Effects of Oxytocin
Mukaddam-Daher, S., Yin, Y.-L., Roy, J., Gutkowska, J., & Cardinal, R. (2001) · Hypertension · doi:10.1161/01.hyp.38.2.292 · Cited by 119 · cited 1×
“A negative inotropic effect of oxytocin has been found in the atrium of dogs [45].”
BackgroundMeasurement of blood loss during postpartum haemorrhage
Lilley, G., Laurent, D. B. S., Precious, E., Bruynseels, D., Kaye, A., Sanders, J., Alikhan, R., Collins, P. W., Hall, J. E., & Collis, R. E. (2014) · International Journal of Obstetric Anesthesia · doi:10.1016/j.ijoa.2014.07.009 · Cited by 117
Prophylactic use of ergot alkaloids in the third stage of labour
Liabsuetrakul, T., Choobun, T., Peeyananjarassri, K., & Islam, Q. M. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005456.pub2 · Cited by 117
Boucher, M., Nimrod, C. A., Tawagi, G., Meeker, T. A., White, R. E. R., & Varin, J. (2004) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)30659-4 · Cited by 117
Human placental transport of oxytocin
Malek, A., Blann, E., & Mattison, D. R. (1996) · The Journal of Maternal-Fetal Medicine · doi:10.1002/(sici)1520-6661(199609/10)5:5<245::aid-mfm3>3.0.co;2-h · Cited by 111 · cited 1×
“Potential mechanisms by which exogenous oxytocin might affect breastfeeding include down-regulation of oxytocin receptors in the mother [61], as well as transplacental passage [62].”
BackgroundCollins, P., Bell, S., de Lloyd, L., & Collis, R. E. (2018) · International Journal of Obstetric Anesthesia · doi:10.1016/j.ijoa.2018.08.008 · Cited by 109 · cited 1×
“There is some evidence that an escalating strategy for the management of increased bleeding after vaginal delivery can reduce postpartum haemorrhage rates [92], and thismay also be applicable at caesarean section [93].”
BackgroundMisoprostol to treat postpartum haemorrhage: a systematic review
Hofmeyr, G. J., Walraven, G. E. L., Gülmezoglu, A. M., Maholwana, B., Alfirević, Ž., & Villar, J. (2005) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2004.00512.x · Cited by 105 · cited 1×
“The most prominent side-effect of misoprostol is hyperpyrexia [86].”
BackgroundST depression at caesarean section and the relation to oxytocin dose. A randomised controlled trial
Jonsson, M., Hanson, U., Lidell, C., & Nordén‐Lindeberg, S. (2009) · BJOG An International Journal of Obstetrics & Gynaecology · doi:10.1111/j.1471-0528.2009.02356.x · Cited by 102 · cited 1×
“Interestingly, one third of episodes of ST depression were either before or after more than 3 min following oxytocin administration, furthering the suggestion that oxytocin is only one of several factors producing ST depression [53].”
BackgroundIntravenous oxytocin bolus of 2 units is superior to 5 units during elective Caesarean section
Sartain, J. B., Barry, J. J., Howat, P., McCormack, D. I., & Bryant, M. (2008) · British Journal of Anaesthesia · doi:10.1093/bja/aen273 · Cited by 98 · cited 1×
“15% of women after 2 IU or 5 IU oxytocin, respectively [58].”
BackgroundMalm, M., Madsen, I., & Kjellström, J. (2018) · Journal of Peptide Science · doi:10.1002/psc.3082 · Cited by 96
George, R. B., McKeen, D. M., Chaplin, A. C., & McLeod, L. (2010) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-010-9297-1 · Cited by 95
Schlembach, D., Helmer, H., Henrich, W., von Heymann, C., Kainer, F., Korte, W. C., Kühnert, M., Lier, H., Maul, H., Rath, W. H., et al. (2018) · Geburtshilfe und Frauenheilkunde · doi:10.1055/a-0582-0122 · Cited by 94
Maternal cardiac troponin I levels during normal labor and delivery
Shivvers, S. A., Wians, F. H., Keffer, J. H., & Ramin, S. M. (1999) · American Journal of Obstetrics and Gynecology · doi:10.1016/s0002-9378(99)70161-4 · Cited by 92
Regional anaesthesia for a Caesarean section in women with cardiac disease: a prospective study
Langesæter, E., Dragsund, M., & Rosseland, L. A. (2009) · Acta Anaesthesiologica Scandinavica · doi:10.1111/j.1399-6576.2009.02080.x · Cited by 91
Leduc, D. C., Senikas, V., & Lalonde, A. B. (2018) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/j.jogc.2018.09.024 · Cited by 91
ST Segment Depression during Labor and Delivery
Mathew, J. P., Fleisher, L. A., Rinehouse, J. A., Sevarino, F. B., Sinatra, R. S., Nelson, A. H., Prokop, E. K., & Rosenbaum, S. H. (1992) · Anesthesiology · doi:10.1097/00000542-199210000-00004 · Cited by 85 · cited 1×
“ST segment changes at caesarean section occur in up to 25–47% of women [47, 48].”
BackgroundKovacheva, V., Soens, M., & Tsen, L. C. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000682 · Cited by 83
Lavoie, A., McCarthy, R. J., & Wong, C. A. (2015) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000000781 · Cited by 81
Adnan, N., Conlan-Trant, R., McCormick, C. A., Boland, F., & Murphy, D. J. (2018) · BMJ · doi:10.1136/bmj.k3546 · Cited by 74
Khan, M., Balki, M., Ahmed, I., Farine, D., Seaward, G. R., & Carvalho, J. C. A. (2013) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-013-0082-9 · Cited by 67
Self-citationWedisinghe, L., Macleod, M., & Murphy, D. J. (2007) · European Journal of Obstetrics & Gynecology and Reproductive Biology · doi:10.1016/j.ejogrb.2007.04.007 · Cited by 65 · cited 1×
“Wedisinghe, UK [15] Lead obstetricians and lead obstetric anaesthetists 365 (84%) 90% slow 12.”
BackgroundMoran, C., Bhuinneáin, M. N., Geary, M. P., Cunningham, S., McKenna, P. J., & Gardiner, J. (2001) · Anaesthesia · doi:10.1111/j.1365-2044.2001.02271.x · Cited by 60
Haemodynamic effects of repeated doses of oxytocin during Caesarean delivery in healthy parturients
Langesæter, E., Rosseland, L. A., & Stubhaug, A. (2009) · British Journal of Anaesthesia · doi:10.1093/bja/aep137 · Cited by 60
Second-line uterotonics and the risk of hemorrhage-related morbidity
Butwick, A. J., Carvalho, B., Blumenfeld, Y. J., El-Sayed, Y. Y., Nelson, L. M., & Bateman, B. T. (2015) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2015.01.008 · Cited by 59 · cited 1×
“A propensity score-matched secondary analysis of registry data investigated the effect of second-line uterotonics given for persistent uterine atony after failed oxytocin prophylaxis [91].”
BackgroundSelf-citationKing, K. J., Douglas, M. J., Unger, W., Wong, A., & King, R. (2010) · Anesthesia & Analgesia · doi:10.1213/ane.0b013e3181f8930a · Cited by 59 · cited 1×
“There were small differences in uterine tone immediately after delivery of the placenta, which was no longer apparent 5 min later [36].”
BackgroundWater intoxication and oxytocin.
Feeney, J. G. (1982) · BMJ · doi:10.1136/bmj.285.6337.243 · Cited by 54 · cited 1×
“Other adverse effects Oxytocin can cause water retention and subsequent hyponatraemia, as the drug has a structural analogy with antidiuretic hormone (ADH; vasopressin), and therefore activates the ADH receptor [55, 56].”
BackgroundSentilhes, L., Vayssière, C., Deneux‐Tharaux, C., Aya, A. G. M., Bayoumeu, F., Bonnet, M., Djoudi, R., Dolley, P., Dreyfus, M., Ducroux-Schouwey, C., et al. (2016) · HAL · Cited by 53
Reyes, O., & González, G. (2011) · Journal of Obstetrics and Gynaecology Canada · doi:10.1016/s1701-2163(16)35077-0 · Cited by 52 · cited 1×
“Although pre-eclampsia and eclampsia are included as contra-indications in the manufacturer’s license, one randomised controlled trial found that the use of carbetocin in patients with severe pre-eclampsia had no major adverse haemodynamic effect [76].”
BackgroundGüngördük, K., Aşıcıoğlu, O., Çelikkol, Ö., Olgaç, Y., & Ark, C. (2010) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2009.01106.x · Cited by 52
Cordovani, D., Balki, M., Farine, D., Seaward, G. R., & Carvalho, J. C. A. (2012) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-012-9728-2 · Cited by 51
Self-citationProstaglandin E2 Analogue Sulprostone for Treatment of Atonic Postpartum Hemorrhage
Schmitz, T., Tararbit, K., Dupont, C., Rudigoz, R.-C., Bouvier‐Colle, M., & Deneux‐Tharaux, C. (2011) · Obstetrics and Gynecology · doi:10.1097/aog.0b013e3182255335 · Cited by 42
Ghosh, S., Bhattacharya, S., Ray, D., Mallick, S., & Laha, A. (2013) · Journal of Anaesthesiology Clinical Pharmacology · doi:10.4103/0970-9185.105790 · Cited by 40 · cited 1×
“ST depression occurred in three out of 40 women when 3 IU oxytocin was given over 15 s, but in none when it was infused over five min [54].”
Duffield, A. T., McKenzie, C. P., Carvalho, B., Ramachandran, B., Yin, V., El-Sayed, Y. Y., Riley, E. T., & Butwick, A. J. (2016) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000001658 · Cited by 38
Self-citationProphylactic use of ergot alkaloids in the third stage of labour
Liabsuetrakul, T., Choobun, T., Peeyananjarassri, K., & Islam, Q. M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd005456.pub3 · Cited by 38
Plested, C. P., & Bernal, A. L. (2001) · Experimental Physiology · doi:10.1113/eph8602187 · Cited by 35 · cited 1×
“Potential mechanisms by which exogenous oxytocin might affect breastfeeding include down-regulation of oxytocin receptors in the mother [61], as well as transplacental passage [62].”
BackgroundAnandakrishnan, S., Balki, M., Farine, D., Seaward, G. R., & Carvalho, J. C. A. (2013) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-013-0028-2 · Cited by 35
Self-citationThe Effect of Oxytocin on the Contractile Force of Human Atrial Trabeculae
Rosaeg, O. P., Cicutti, N. J., & Labow, R. S. (1998) · Anesthesia & Analgesia · doi:10.1097/00000539-199801000-00008 · Cited by 33
Nguyen-Lu, N., Carvalho, J. C. A., Farine, D., Seaward, G. R., Ye, X. Y., & Balki, M. (2015) · Canadian Journal of Anesthesia/Journal canadien d anesthésie · doi:10.1007/s12630-015-0375-2 · Cited by 32 · cited 3×
“However, doses higher than 100 lg have been associated with cardiovascular complications such as tachycardia and intra-operative arrhythmias, and cannot currently be recommended [71].”
BackgroundMethodSelf-citationTransfer of carbetocin into human breast milk.
Silcox, J. A., Schulz, P., Horbay, G. L. A., & Wassenaar, W. G. (1993) · PubMed · Cited by 21
Impact of dose‐finding studies on administration of oxytocin during caesarean section in the UK
West, R., West, S. J., SIMONS, R. S., & McGlennan, A. (2013) · Anaesthesia · doi:10.1111/anae.12381 · Cited by 19
Rumboll, C. K., Dyer, R. A., & Lombard, C. J. (2015) · International Journal of Obstetric Anesthesia · doi:10.1016/j.ijoa.2015.08.003 · Cited by 19
Self-citationCole, N. M., Carvalho, J. C. A., Erik‐Soussi, M., Ramachandran, N., & Balki, M. (2015) · Anesthesiology · doi:10.1097/aln.0000000000000940 · Cited by 19
Self-citationMockler, J. C., Murphy, D. J., & Wallace, E. M. (2010) · Australian and New Zealand Journal of Obstetrics and Gynaecology · doi:10.1111/j.1479-828x.2009.01108.x · Cited by 19 · cited 1×
“Mockler, Australia and NewZealand [17] Obstetric fellows (members of Royal Australian andNewZealand College of Obstetricians and Gynaecologists) 700 (45%) 32% 67% 68different infusion regimens; most common is 40 IU in 1 l over 4 h Ergometrine – 26% Syntometrine (oxytocin 5 IU + ergometrine 500 lg) – 20% Oxytocin bolus…”
BackgroundTabl, S., Balki, M., Downey, K., TOMLINSON, G. A., Farine, D. R., Seaward, G. R., & Carvalho, J. C. A. (2018) · Anaesthesia · doi:10.1111/anae.14480 · Cited by 18
Self-citationRETIRED: Guidelines for Oxytocin Administration after Birth: AWHONN Practice Brief Number 2
(2014) · Journal of Obstetric, Gynecologic & Neonatal Nursing · doi:10.1111/1552-6909.12528 · Cited by 14
Murphy, D. J., Carey, M., Montgomery, A. A., Sheehan, S. R., & The ECSSIT Study Group (2009) · BMC Pregnancy and Childbirth · doi:10.1186/1471-2393-9-36 · Cited by 13
Foley, A., Gunter, A., Nunes, K. J., Shahul, S. S., & Scavone, B. M. (2017) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000002401 · Cited by 13
Lavoie, A., McCarthy, R. J., & Wong, C. A. (2016) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000482625.50195.80 · Cited by 12
Orbach‐Zinger, S., Einav, S., Yona, A., Eidelman, L. A., Fein, S., Davis, A., & Ioscovich, A. (2017) · The Journal of Maternal-Fetal & Neonatal Medicine · doi:10.1080/14767058.2017.1366981 · Cited by 6 · cited 2×
“Orbach-Zinger, Israel [20] Obstetricians and anaesthetists; six university hospitals; all grades 390 (90%) 1 IU 5 IU 10 IU 10 IU in 1 l Ringer’s lactate 20 IU in 1 l Ringer’s lactate Second line – usually increased bolus of oxytocin or increase rate Third-linemethylergometrine First CS 4.”
BackgroundSelf-citation
Cited by
Bollag, L., Lim, G., Sultan, P., Habib, A. S., Landau, R., Zakowski, M., Tiouririne, M., Bhambhani, S., & Carvalho, B. (2021) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000005257 · Cited by 378
Self-citationSultan, P., Nelson, G., Joudi, K., Singh, D. J., Gregory, K. D., Zakowski, M., Carvalho, B., Bekemeyer, Z., Ciechanowicz, S., Dellapiana, G., et al. (2026) · International Journal of Obstetric Anesthesia · doi:10.1016/j.ijoa.2025.104811 · Cited by 3
Self-citationRecommended Interventions for Enhanced Recovery After Cesarean Delivery in the United States
Sultan, P., Zakowski, M., Joudi, K., Singh, D., Gregory, K. D., Lyell, D., Carvalho, B., & Study investigators (2024) · doi:10.1101/2024.11.05.24316713 · Cited by 1
Self-citation
Metadata
- Authors
- Heesen, M., Carvalho, B., Carvalho, J. C. A., Duvekot, J. J., Dyer, R. A., Lucas, D. N., McDonnell, N., Orbach‐Zinger, S., & Kinsella, S. M.
- Venue
- Anaesthesia
- Publisher
- Wiley
- Published
- 2019-07-25
- Volume
- 74
- Issue
- 10
- Pages
- 1305-1319
- ISSN
- 0003-2409 (ISSN-L)
- 1365-2044
- OpenAlex
- W2965442196
- Cited by
- 187
- References
- 80
- FWCI
- 17.20
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.